Related Experiment Video
Updated: Jan 17, 2026
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
COPZ1: an example of non-oncogene addiction in human tumors
Tiziana Di Marco1, Debora Vergaro1, Angela Greco1
1Integrated Biology of Rare Tumors Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Abstract:
Non-oncogene addiction (NOA) indicates that tumor cell growth/survival requires the activity of genes/pathways not oncogenic per sé, and dispensable for normal cells. NOA genes provide a wide repertoire of novel therapeutic exploitable tumor vulnerabilities. A large body of evidence demonstrates the dependency of several tumors such as breast, prostate, ovary, thyroid, glioblastoma and LUAD, on the activity of COPZ1, a component of the heptameric COPI complex. Thus, COPZ1 is emerging as a potential novel therapeutic target for tumors of different origin. In different tumor models COPZ1 inhibition was found implicated in abortive autophagy, ER stress and activation of ferroptosis. In this review we summarize the different studies characterizing COPZ1 as a NOA gene in different tumor types, and discuss potential issues related to its targeting.
Insights
Non-oncogene addiction (NOA) highlights tumor vulnerabilities. COPZ1, a COPI complex component, is crucial for various cancer cell growth, making it a promising therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Non-oncogene addiction (NOA) describes tumor cell dependencies on non-oncogenic genes.
- These NOA genes represent novel therapeutic targets for cancer treatment.
- COPZ1, a component of the COPI complex, is implicated in the growth of multiple tumor types.
Purpose of the Study:
- To review the role of COPZ1 as a NOA gene across various cancers.
- To discuss the therapeutic potential and challenges of targeting COPZ1.
Main Methods:
- Literature review of studies on COPZ1 in different tumor models.
- Analysis of COPZ1's involvement in cellular processes like autophagy, ER stress, and ferroptosis.
Main Results:
- COPZ1 dependency is demonstrated in breast, prostate, ovary, thyroid, glioblastoma, and LUAD.
- COPZ1 inhibition triggers abortive autophagy, ER stress, and ferroptosis in tumor cells.
- COPZ1 emerges as a potential therapeutic target due to its non-oncogenic addiction role.
Conclusions:
- COPZ1 is a validated NOA gene across diverse cancer types.
- Targeting COPZ1 presents a promising therapeutic strategy for various malignancies.
- Further research is needed to address challenges associated with COPZ1 inhibition.
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:06Induced Pluripotent Stem Cells
Somatic...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...